Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer

WEE1 and CHEK1 (CHK1) kinases are critical regulators of the G2/M cell cycle checkpoint and DNA damage response pathways. The WEE1 inhibitor AZD1775 and the CHK1 inhibitor SRA737 are in clinical trials for various cancers, but have not been examined in prostate cancer, particularly castration-resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiming, Chao, Yapeng, Chen, Yuzhou, Zheng, Wenxiao, Demanelis, Kathryn, Liu, Yu, Connelly, Jaclyn, Wang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659531/
https://www.ncbi.nlm.nih.gov/pubmed/37987002
http://dx.doi.org/10.21203/rs.3.rs-3564450/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659531/
https://www.ncbi.nlm.nih.gov/pubmed/37987002
http://dx.doi.org/10.21203/rs.3.rs-3564450/v1

Ejemplares similares